Datavant · 2 months ago
CDQI Nurse Specialist - Part Time - Remote
Datavant is a data platform company and the world’s leader in health data exchange. As a Clinical Documentation Quality Improvement (CDQI) Specialist, you will enhance medical record documentation by conducting evaluations and collaborating with healthcare providers to ensure clarity and completeness. This role is crucial for improving coding specificity and the overall quality of patient care.
BiopharmaClinical TrialsData IntegrationHealth CareSoftware
Responsibilities
Conduct timely, accurate, and complete documentation reviews for selected inpatient records, addressing inadequate or conflicting documentation
Collaborate with physicians and caregivers to ensure appropriate reimbursement and clinical severity for DRG-based payer patients
Demonstrate understanding of complications, co-morbidities, severity of illness, risk of mortality, case mix index, secondary diagnoses, and procedure impact on DRG
Improve coding specificity by educating physicians and caregivers on the importance of clear documentation throughout a patient's stay
Follow AHA guidelines and coding clinics for accurate coding and required documentation to ensure compliance
Query physicians regarding missing, unclear, or conflicting health record documentation to obtain necessary details
Maintain daily production logs for evaluation, tracking cases reviewed, queries placed/responded, etc
Perform follow-up reviews to confirm recorded points of clarification in the patient's medical record
Ensure confidentiality of all files, documents, and records
Meet or exceed production and quality metrics
Qualification
Required
3+ years of CDI experience
3+ years of clinical experience in an academic medical center
Registered Nurse license, Bachelor's degree in Nursing
CCDS or CDIP certification required
Must pass a CDI skills competency assessment
Must be able to accommodate a min of 15 hours per week
Company
Datavant
Datavant protects, connects, and delivers the world’s health data to power better decisions and advance human health.
Funding
Current Stage
Late StageTotal Funding
$80.5MKey Investors
Transformation Capital
2020-10-08Series B· $40M
2018-04-30Series Unknown· $40.5M
Recent News
2025-12-31
2025-12-19
Company data provided by crunchbase